Covid-19

Eye on large-cap pharma and biotech

Investors must study what 'fear' means

New chief looks back at one year at helm of firm

European equities have declined 26% during 2020 owing to the rapid spread of the Covid-19 pandemic. Consequently, economic activity indices have declined to multi-year lows.

Is a more balanced market around the corner?

Amid the increasingly sobering economic projections and single issue news coverage, it is easy to become blinkered.

Crude futures seesaw between negative territory and recovery

Catching up with last year's Trailblazer Awards winners

The international spread of Covid-19 has spooked markets into some of their worst days since 1987.

Investment veteran offers advice to investors